Lantern Pharma (LTRN) vs NuCana (NCNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Lantern Pharma is the larger company by market cap ($3.9 million vs $3.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LTRN | NCNA |
|---|---|---|
| Share price | $0.245 | $0.7495 |
| Market cap | $3.89M | $3.61M |
| 1-day change | -13.73% | +4.39% |
| YTD return | -91.91% | — |
| 1-year return | -91.89% | — |
| 5-year return | -97.27% | — |
| EPS (TTM) | $-1.44 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-17.12M | — |
| 52-week high | $4.34 | $4.55 |
| 52-week low | $0.2286 | $0.62 |
| Distance from 52-week high | -94.35% | -83.53% |
| Analyst consensus | none | — |
| Avg. price target upside | +7042.86% | — |
| Average volume | 249.66K | 118.13K |
| Shares outstanding | 15.89M | 4.82M |
| Employees | 16 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lantern Pharma
LTRN stock →Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India.
Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees
About NuCana
NCNA stock →NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
LTRN vs NCNA FAQ
Which is bigger, Lantern Pharma or NuCana?
Lantern Pharma (LTRN) is larger, with a market capitalization of $3.89M compared with $3.61M for NuCana (NCNA).
Are Lantern Pharma and NuCana in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.